[1]
Adil, B. et al. 2023. Add-On Therapy of Dapagliflozin to Metformin in Patients with Diabetes Mellitus Type-2; Efficacy and Renal Safety. Pakistan Armed Forces Medical Journal. 73, SUPPL-1 (Jul. 2023), S148–151. DOI:https://doi.org/10.51253/pafmj.v73iSUPPL-1.4642.